A history of diabetes predicts outcomes following myocardial infarction: an analysis of the 28 771 patients in the High-Risk MI Database

Validity and Reliability of Self-reported Diabetes in the Atherosclerosis Risk in Communities Study

(2012) A. L. C. Schneider et al.   AMERICAN JOURNAL OF EPIDEMIOLOGY

Hypo- and Hyperglycemia Predict Outcome in Patients With Left Ventricular Dysfunction After Acute Myocardial Infarction: Data From EPHESUS

(2012) Christian Ukena et al.   JOURNAL OF CARDIAC FAILURE

The High-Risk Myocardial Infarction Database Initiative

(2012) Kenneth Dickstein et al.   PROGRESS IN CARDIOVASCULAR DISEASES

Long-Term Prognostic Importance of Diabetes After a Myocardial Infarction Depends on Left Ventricular Systolic Function: Figure 1

(2011) Charlotte Andersson et al.   DIABETES CARE

Heart in Diabetes: A Microvascular Disease

(2011) M. Laakso   DIABETES CARE

Impact of diabetes mellitus on outcomes in patients with acute myocardial infarction and systolic heart failure

(2011) Prakash C. Deedwania et al.   EUROPEAN JOURNAL OF HEART FAILURE

Metabolic memory: a vascular perspective

(2010) Thomas W Jax   Cardiovascular Diabetology

The inter-relationship of diabetes and left ventricular systolic function on outcome after high-risk myocardial infarction

(2010) Amil M. Shah et al.   EUROPEAN JOURNAL OF HEART FAILURE

Trends in All-Cause and Cardiovascular Disease Mortality Among Women and Men With and Without Diabetes Mellitus in the Framingham Heart Study, 1950 to 2005

(2009) Sarah Rosner Preis et al.   CIRCULATION

Impact of Diabetes Mellitus on Rehospitalization for Heart Failure Among Survivors of Acute Myocardial Infarction in the Percutaneous Coronary Intervention Era

(2009) Daisaku Nakatani et al.   CIRCULATION JOURNAL

The Hemoglobin A1c Level as a Progressive Risk Factor for Cardiovascular Death, Hospitalization for Heart Failure, or Death in Patients With Chronic Heart Failure

(2008) Hertzel C. Gerstein   ARCHIVES OF INTERNAL MEDICINE

Impact of diabetes on outcomes in patients with low and preserved ejection fraction heart failure: An analysis of the Candesartan in Heart failure: Assessment of Reduction in Mortality and morbidity (CHARM) programme

(2008) M. R. MacDonald et al.   EUROPEAN HEART JOURNAL